T4 RNA Ligase 1

T4 RNA Ligase 1 Liste de produits

  • Attribut

    Protein (1)

  • Bibliothèque de produits

    En ligne (1)

  • Espèces

    Escherichia phage T4 (1)

  • Étiquette

    His Tag (1)

  • Marqueur

    Unconjugated (1)

Numéro de produitEspècesSystème d'expressionDescription du produitStructure protéiquePuretéCaractéristiquesPré-commande/Commande
Escherichia phage T4
E. coli
T4 RNA Ligase 1(10U/ul) Ajouter au panier
Quantité totale1
  • 1

T4 RNA Ligase 1Contexte de la molécule

Circular RNAs (circRNA) is a class of natural (biogenic) or synthetic closed RNA without 5' or 3' ends. Meanwhile, their unique covalently-closed structures of circRNA prevent RNA degradation by exonucleases, thereby empowering them with high pharmaceutical stability and biostability relative to current standard-of-care linear mRNA. Natural circRNA can be non-coding RNAs as well as protein-coding RNA, the latter of which was recently discovered. The physiological functions of biogenic circRNAs, which largely remain elusive, include protein and gene sponges, cell activity modulators, and protein translation. The discovery that the circRNA levels can be correlated with some human diseases empowers circRNA with the potential as a novel type of disease biomarkers and a noncanonical class of therapeutic targets. Recently, synthetic circRNA have been engineered to explore their applications as a novel class of mRNA therapeutics and vaccines.(Liu, Xiang et al. “Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines.” Journal of controlled release : official journal of the Controlled Release Society vol. 348 (2022): 84-94. doi:10.1016/j.jconrel.2022.05.043)

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
ItolizumabT-1-hT; EQ-001; T-1-h; h-T1; Bmab-600ApprovedBiocon Ltd, Center Of Molecular Immunology, Biotech Pharmaceuticals Co LtdAlzumabIndiaPlaque psoriasisBiocon Ltd2013-01-01Dermatomyositis; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Coronavirus Disease 2019 (COVID-19); Lupus Nephritis; Respiratory Distress Syndrome, Adult; Psoriasis; Asthma; Plaque psoriasis
Details
  • Liste de produits
  • Informations sur les médicaments commercialisés